Showing results (311-320 of 370) with videos related to
Sort By:
Pageof 37
BJU International|October 11, 2019
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.Urology|April 26, 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc ProstatesAnis Assad, David-Dan Nguyen, Neil Barber, et al.Journal of Endourology|January 5, 2021
A Novel Method for GreenLight MoXy Laser Fiber Irrigation System to Improve Performance and Durability: A New Standard of Care?Kyle W Law, Ahmed S Zakaria, Dean S Elterman, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 20, 2014
The impact of resident involvement in minimally-invasive urologic oncology proceduresNedim Ruhotina, Julien Dagenais, Giorgio Gandaglia, et al.BJU International|March 13, 2016
Assessment of energy density usage during 180W lithium triborate laser photoselective vaporization of the prostate for benign prostatic hyperplasia. Is there an optimum amount of kilo-Joules per gram of prostate?Roger Valdivieso, Christian P Meyer, Pierre-Alain Hueber, et al.BJUI Compass|November 14, 2024
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30-80-cm3 and 80-150-cm3 prostatesMohamad Baker Berjaoui, David-Dan Nguyen, Saud Almousa, et al.European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm3 and 80-150-cm3 ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.Urology|November 19, 2013
180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parametersPierre-Alain Hueber, Daniel Liberman, Tal Ben-Zvi, et al.Medrxiv : the Preprint Server for Health Sciences|January 4, 2022
SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and OmicronMatthew T Laurie, Jamin Liu, Sara Sunshine, et al.Radiation Oncology (London, England)|April 26, 2019
Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostateVincent Q Trinh, Nazim Benzerdjeb, Ségolène Chagnon-Monarque, et al.Pageof 37